Himachal govt to implement Bulk Drug Park Project on its own, says CM Sukhu
Shimla: The government of Himachal Pradesh will do the implementation of the Bulk Drug Park Project worth Rs 1,000 crore on its own, Chief Minister Sukhvinder Singh Sukhu said.
The land and electricity will also be provided at subsidised rates to the investors, he added.
The project aims to set up a mega drug manufacturing facility spanning 570 hectares in the Haroli assembly segment of Una district.
Intervening during Industries Minister Harshwardhan Chauhan’s reply to a question by Congress’s Kewal Singh Pathania on the Bulk Drug Park, Sukhu said the terms and conditions of the project would be revised after 10 years.
Water and electricity would be supplied at commercial rates and charges would be levied for waste, solid waste, and steam management, he added.
As per PTI report, Sukhu also blamed the previous BJP government for allegedly failing to secure the interests of the state while signing memorandums of understanding for hydropower and other projects.
Agreements for Dhaulasidh, Luhri and Sunni hydropower projects were signed against the interests of the state, he alleged.
In his reply, Chauhan said the state government has decided to execute the project on its own by spending Rs 1,000 crore and it would be completed by March 31, 2026.
The state government will soon return the Rs 30 crore given by the Union government for this project, he added.
According to the terms and conditions, power would be supplied to the investors at Rs 3 per unit despite the government purchasing it at Rs 7 per unit, he said.
Work on the project has begun and Rs 50 crore has been sanctioned. The project is expected to attract investments worth Rs 50,000 crore and give employment to 20,000 people, he said.
The project would be implemented by the State Implementing Agency under the Himachal Pradesh Bulk Drug Park Infrastructure Limited, the minister said.
Read also: Provide additional financial aid for Una Bulk Drug Park: Himachal CM urges J P Nadda
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.